In breast cancer cells, adiponectin increases serine–threonine liver kinase B1 (LKB1) expression, which can negatively impact cell proliferation, increase apoptosis, decrease aromatase activity, an reduce invasive capacity (42). This evidence concerns the gene CYP19A1 and breast carcinoma.